Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05327829 · ClinicalTrials.gov registry record · Early Phase 1

Stimulating After Recovery From Traumatic Brain Injury

A Early Phase 1 study of TBI (Traumatic Brain Injury), sponsored by University of Minnesota.

Recruiting
Registry status
Early Phase 1
Development phase
30
Enrollment target
1
Study location

NCT05327829 is a Early Phase 1 study of TBI (Traumatic Brain Injury) that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 172-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05327829, a Early Phase 1 study of TBI (Traumatic Brain Injury), is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
Early Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.

Interventions

  • COMBINATION_PRODUCT External non-invasive stimulation
  • BEHAVIORAL COGED

Study Locations (1)

Minnesota

  • Hennepin County Medical Center - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-15
Est. Completion 2028-01-15
Phase Early Phase 1

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05327829

The ClinicalTrials.gov registry entry for NCT05327829 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 172-participant average among 20 other TBI (Traumatic Brain Injury) trials with a reported enrollment target (83% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with TBI (Traumatic Brain Injury) appearing as the primary indexed condition, and to 2 interventions - of which External non-invasive stimulation is the first listed.

NCT05327829 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05327829 about?

NCT05327829 is a clinical study titled "Stimulating After Recovery From Traumatic Brain Injury". This is a preliminary, prospective interventional study to investigate the feasibility of using transcutaneous alternating current stimulation (TACS) after a traumatic brain injury (TBI) to improve cognitive function and decision-making.

What is the current status of trial NCT05327829?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2025-01-15. Estimated completion is 2028-01-15.

What conditions does trial NCT05327829 study?

This clinical trial studies the following conditions: TBI (Traumatic Brain Injury).

What interventions are being tested in trial NCT05327829?

The interventions under investigation include: External non-invasive stimulation (COMBINATION_PRODUCT), COGED (BEHAVIORAL).

Who is sponsoring clinical trial NCT05327829?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05327829 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for TBI (Traumatic Brain Injury)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.